Jared Kaltwasser

A smartphone app is associated with improvement in HbA1c levels, but physician involvement with patients and other factors may be the benefit.

The number of digital therapeutics available for migraine is likely to expand.

Preventive care, health insurance literacy and a digital health shakeout are in the crystal ball

Medication only works when it's taken, which makes adherence necessary. The approach can't be "one size fits all".

As a health plan worked to boost medication adherence among members, it made a startling discovery.

Novo Nordisk’s Saxenda (liraglutide) and Wegovy (semaglutide) are leading the way for a new crop of drugs that reduce appetite, but the cost-effectiveness is in question with many payers saying no to coverage.

Although one in 12 controlled substances medication transactions at US hospitals involve suspicious variations, only about half of such transactions are ever investigated.

The findings paint a mixed picture, though, as stimulant use in patients with OUD was also associated with an increased risk of drug poisoning.

The company is producing repair kits and replacement devices, but those efforts have led to a shortage of devices.

Data suggest a smartphone application can boost physical activity and relieve symptoms of chronic obstructive pulmonary disease.